brequinar has been researched along with concanavalin a in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Harris, RR; Jaffee, BD; Jones, EA; Simon, P; Townsend, RM | 1 |
| Bakri, MT; Tamura, K; Thomson, AW; Woo, J | 1 |
| Fung, JJ; Lemster, B; Starzl, TE; Thomson, AW; Todo, S; Woo, J | 1 |
3 other study(ies) available for brequinar and concanavalin a
| Article | Year |
|---|---|
Brequinar sodium: inhibition of dihydroorotic acid dehydrogenase, depletion of pyrimidine pools, and consequent inhibition of immune functions in vitro.
Topics: Animals; Biphenyl Compounds; Cells, Cultured; Concanavalin A; Dihydroorotate Oxidase; Humans; Immunity; Immunoassay; Immunosuppressive Agents; Lymphocyte Activation; Lymphocyte Culture Test, Mixed; Lymphocytes; Nucleotides; Pyrimidines; Rats; Rats, Inbred Lew; Swine; Swine, Miniature | 1993 |
Brequinar sodium inhibits interleukin-6-induced differentiation of a human B-cell line into IgM-secreting plasma cells.
Topics: B-Lymphocytes; Biphenyl Compounds; Cell Differentiation; Cell Line; Concanavalin A; Cytidine; DNA; Humans; Immunoglobulin M; Immunosuppressive Agents; Interleukin-6; Pyrimidines; Uridine | 1993 |
Potentiation of the antiproliferative activity of brequinar sodium for murine lymphocytes by exogenous cytidine.
Topics: Animals; Biphenyl Compounds; Cells, Cultured; Concanavalin A; Cytidine; Dose-Response Relationship, Drug; Drug Synergism; Immunosuppressive Agents; Interleukin-2; Interleukin-4; Lymphocyte Activation; Lymphocytes; Male; Mice; Mice, Inbred C57BL; RNA, Messenger; Spleen | 1993 |